• D-Lin-MC3-DMA: Scientific Advances in Ionizable Liposome Del

  2026-07-24

  Explore the scientific breakthroughs of D-Lin-MC3-DMA, a leading ionizable cationic liposome for siRNA and mRNA delivery. This article uniquely examines the integration of machine learning insights with molecular mechanisms, providing a practical guide for advanced nucleic acid therapeutics.

• Intravesical p21 mRNA-LNP Therapy: Restoring Tumor Suppressi

  2026-07-24

  The referenced study demonstrates that intravesical delivery of p21 mRNA encapsulated in lipid nanoparticles (LNPs) achieves robust tumor suppressor restoration and suppresses tumor growth in non–muscle-invasive bladder cancer models. This approach leverages localized, non-viral mRNA therapy to address recurrence and resistance associated with current treatments, marking a significant advance in precision oncology.

• Triacetin Digestion Reveals Dual Metabolic and Regulatory Ro

  2026-07-23

  This study offers the first detailed mapping of triacetin digestion and absorption in rats, showing rapid conversion to acetic acid and glycerol in the upper gut. The findings highlight triacetin’s dual function as both an energy substrate and a regulator of hepatic gene expression, with implications for metabolic disease research and dietary interventions.

• GSK343: Precision EZH2 Inhibitor Workflows in Cancer Researc

  2026-07-23

  GSK343, a potent and selective EZH2 inhibitor, empowers researchers to dissect epigenetic mechanisms underlying cancer cell proliferation and gene repression with unmatched specificity. This article delivers actionable workflows, troubleshooting strategies, and translational insights that position GSK343 from APExBIO as an indispensable tool for reproducible, high-impact epigenetic research.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-07-22

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific detection of goat IgG primary antibodies in fluorescence-based assays such as ICC/IF, IHC, flow cytometry, and ELISA. It is not suitable for non-goat primaries or for non-fluorescent detection formats. Researchers should follow established storage, handling, and workflow protocols to maximize signal and minimize background.

• BMS 599626 dihydrochloride: Reliable EGFR/ErbB2 Inhibition f

  2026-07-22

  This article delivers scenario-driven, evidence-backed guidance on integrating BMS 599626 dihydrochloride (SKU B5792) into cancer and senescence research workflows. It addresses real laboratory challenges in EGFR/ErbB2 inhibition, protocol optimization, and product selection, supporting reproducible, high-sensitivity cell-based assays.

• RAB31 Governs an ESCRT-Independent Exosome Biogenesis Pathwa

  2026-07-21

  This study identifies RAB31 as a key regulator marking and controlling a novel ESCRT-independent pathway for exosome biogenesis. By elucidating RAB31’s dual role in intraluminal vesicle formation and lysosomal avoidance, the paper provides foundational insights for exosome biology and new angles for molecular trafficking research.

• Amitriptyline HCl: Technical Guidance for Neuropharmacology

  2026-07-21

  Amitriptyline HCl (SKU B2231) enables precise neurotransmitter receptor modulation in neuropharmacology, mood disorder, and neurodegenerative disease research. Best used for experiments requiring rapid solution preparation and strict quality control, it is not recommended for protocols needing long-term solution storage or unvalidated assay conditions.

• Exemestane: Molecular Precision for Estrogen Modulation in R

  2026-07-20

  Explore how Exemestane, a selective steroidal aromatase inhibitor, enables high-fidelity estrogen biosynthesis inhibition and advances the mechanistic toolkit for breast cancer research. This in-depth article uniquely deciphers molecular action, assay impact, and protocol optimization.

• Strategic Neddylation Inhibition: MLN4924 in Translational O

  2026-07-20

  This thought-leadership article examines the mechanistic foundation and translational promise of MLN4924, a potent NEDD8-activating enzyme inhibitor, for researchers targeting the neddylation pathway in cancer. Integrating new insights on the UBE2F-SAG axis and mTORC1-driven liver tumorigenesis, it provides evidence-based recommendations, protocol guidance, and a competitive perspective on deploying MLN4924 in advanced cancer biology research.

• High-Throughput BBB Model: Accurate CNS Drug Permeability Pr

  2026-07-19

  This study presents a validated high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, integrating lysosomal trapping correction for enhanced prediction of CNS drug permeability. The approach enables robust discrimination of passive diffusion and active transport, streamlining early-phase neurological drug screening.

• ARCA EGFP mRNA: Mechanistic Insight and Translational Levera

  2026-07-18

  This thought-leadership article dissects the mechanistic advantages and strategic implications of ARCA EGFP mRNA for translational researchers optimizing gene expression and delivery in mammalian cells. Integrating recent advances from lipid nanoparticle therapeutics, the piece offers practical guidance on leveraging direct-detection reporter mRNA for workflow reliability, benchmarking, and innovation in nucleic acid delivery.

• Advancing mRNA Transfection Controls: From Mechanism to Tran

  2026-07-17

  This article provides translational researchers with a mechanistic and strategic guide to deploying ARCA EGFP mRNA as a next-generation mRNA transfection control. It bridges foundational biochemistry, experimental benchmarking, and emerging delivery paradigms—grounded in the latest lipid nanoparticle research—to inform optimal assay design and future therapeutic translation. It also distinguishes its scope by integrating evidence from both product data and recent cross-domain advances in nucleic acid delivery.

• EZH2-Mediated Protection Against H2O2-Induced Endothelial Dy

  2026-07-17

  This study demonstrates that salidroside (SAL) mitigates hydrogen peroxide-induced dysfunction in human endothelial cells by regulating inflammation and autophagy via EZH2 signaling. Findings highlight the therapeutic potential of targeting EZH2 to protect vascular endothelium from oxidative stress, with implications for cardiovascular disease research.

• Açaí Extracts: Hepatocyte Cytotoxicity and Minimal CYP Induc

  2026-07-16

  This study provides one of the most detailed in vitro evaluations of açaí (Euterpe oleracea) extract effects on human hepatocytes, focusing on cytotoxicity and their potential to modulate cytochrome P450 enzymes and drug transporters. The findings reveal extract- and dose-dependent cytotoxicity but no significant induction of key metabolic enzymes or transporters, informing risk assessment for botanical-drug interactions.

8522 records 5/569 page Previous Next 12345 下5页 Last page